In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.
Magazine
Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.
We would like to announce our new partnership with Devicare, S.L., to bring Utipro Plus AF into the Spanish market! We're excited about this new alliance and grateful for the trust placed in us.
Interested in exploring business opportunities with us? Contact us! https://noventure.com/contact-us
GREAT NEWS! Noventure is delighted to announce that our medical device Tasectan has just been granted a new CЄ Certificate under MDR Regulation.
